...
首页> 外文期刊>Frontiers in Cardiovascular Medicine >White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study
【24h】

White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study

机译:白细胞计数高密度脂蛋白胆固醇的比例,作为经皮冠状动脉干预后患者长期不良结果的新预测因子:回顾性队列研究

获取原文
           

摘要

Background: White blood cell (WBC) counts and high-density lipoprotein cholesterol (HDL-C) are widely available in clinical practice. However, the predictive value for cardiovascular disease (CVD) is uncertain. In the present study, we firstly assessed the prognostic value of WBC to HDL-C ratio (WHR) in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). Methods: Six thousand and fifty patients with CAD after PCI from a retrospective cohort study (identifier: ChiCTR-INR-16010153) were evaluated initially. Three hundred and seventy-one patients were excluded due to HDL cholesterol data not available, malignancy, dementia, psoriasis or eczema, systemic connective tissue disorders, multiple sclerosis, chronic liver disease, and chronic obstructive pulmonary disorder. Finally, 5,679 patients were included in the study. The primary outcome was long-term mortality. Secondary endpoints were mainly major adverse cardiovascular and cerebrovascular events (MACCEs), defined as a combination of stroke, cardiac death, stent thrombosis, recurrent myocardial infarction, and target vessel revascularization. The mean follow-up time of this study was 35.9 ± 22.5 months. We defined the best cutoff value of MHR according to the receiver operating curve (ROC), and then patients were divided into high and low WHR groups according to the cutoff value. We analyzed the data in both an acute coronary syndrome group (ACS) and a stable CAD subgroup, respectively. Results: Overall, there were 293 cases of long-term mortality during the follow-up period. According to the cutoff value (WHR = 8.25), 1,901 ACS patients were divided into high WHR group ( n = 724) and low WHR group ( n = 1,177). Compared to low WHR group, the incidence of all-cause mortality (ACM, 5.5 vs. 3.6%, p = 0.048) and cardiac death (4.7vs. 2.9%, p = 0.042) were significantly higher in the high WHR group. In stable CAD group, we also found the incidence of ACM and cardiac death were significantly higher in the high group compared to that in the low group. We did not find significant difference between the high and the low WHR group in the incidence of MACCEs. The multivariate Cox proportional hazards model showed that increased WHR level was independently correlated with the mortality. In the high WHR group, the risk of ACM increased two times in ACS [adjusted HR = 2.036 (1.258–3.296), p = 0.004] and 1.5 times in stable CAD [adjusted HR = 1.586 (1.178–2.136), p = 0.002]. Conclusion: The present study indicated that an increased WBC count to HDL-C ratio was independently associated with long-term mortality in CAD patients who underwent PCI.
机译:背景:白细胞(WBC)计数和高密度脂蛋白胆固醇(HDL-C)在临床实践中广泛可用。然而,心血管疾病(CVD)的预测值是不确定的。在本研究中,我们首先评估了WBC对HDL-C比率(WHR)的预后值(CAD),冠心病(CAD)接受经皮冠状动脉介入(PCI)。方法:从回顾性队列研究(标识符:CHICTR-INR-16010153)评估PCI后六千和五十名CAD患者,最初评估。由于HDL胆固醇数据不可用,恶性肿瘤,痴呆,牛皮癣或湿疹,全身结缔组织疾病,多发性硬化症,慢性肝病和慢性阻塞性肺病症,被排除了三百七十一名患者。最后,研究中包含5,679名患者。主要结果是长期死亡率。次要终点主要是主要的不良心血管和脑血管事件(MAX),定义为中风,心脏死亡,支架血栓形成,复发性心肌梗死和靶血管血运重建的组合。本研究的平均随访时间为35.9±22.5个月。我们根据接收器操作曲线(ROC)定义了MHR的最佳截止值,然后根据截止值分为高低WHR组。我们分析了急性冠状动脉综合征组(ACS)和稳定的CAD子组中的数据。结果:总体而言,随访期间有293例长期死亡率。根据截止值(WHR = 8.25),1,901名ACS患者分为高WHR组(n = 724)和低WHR组(n = 1,177)。与低WHR组相比,HIGH WHR组中,全导致死亡率的发生率(ACM,5.5,3.6%,P = 0.048)和心脏死亡率(2.9%,P = 0.042)显着高。在稳定的CAD组中,我们还发现,与低群体相比,高分组的ACM和心脏死亡显着高。在MOM的发病率下,我们在高高的WHR组之间没有发现显着差异。多变量Cox比例危险模型显示,增加的WR水平与死亡率不同。在高WHR组中,ACM的风险在ACS中增加了两次[调整后的HR = 2.036(1.258-3.296),P = 0.004]和1.5倍在稳定的CAD中[调整后的HR = 1.586(1.178-2.136),p = 0.002 ]。结论:本研究表明,WBC的增加与HDL-C比的增加与接受PCI的CAD患者的长期死亡率与HDL-C的比例不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号